Arthneeti

Brooks Laboratories Share Price & Earnings Call Analysis

₹64.56+1.73% today
Market cap
₹190 Cr
P/E
14.40
ROE
22.00%
PEG
0.31
Price to sales
2.28
Debt to equity
0.07
52W high / low
₹112 / ₹37.1
Sales growth (5Y)
2.11%
EBITDA margin
3.11%
Net profit margin
28.33%
Promoter holding
52.62%
Sales (last year)
₹83 Cr

Potential multibaggers · Q2 FY27

This quarter's potential multibaggers
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Brooks Laboratories rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Financials of Brooks Laboratories

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Brooks Laboratories

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +15.3012.6115.7024.3221.7517.7217.9320.7920.5223.3225.5123.4516.57
Expenses +23.8516.3119.6125.4225.1227.2519.8524.2022.0224.5822.3820.9315.84
Operating Profit-8.55-3.70-3.91-1.10-3.37-9.53-1.92-3.41-1.50-1.263.132.520.73
OPM %-55.88%-29.34%-24.90%-4.52%-15.49%-53.78%-10.71%-16.40%-7.31%-5.40%12.27%10.75%4.41%
Other Income +0.450.030.050.090.160.650.070.200.030.627.156.135.32
Interest0.750.180.170.190.210.270.160.320.280.260.300.280.16
Depreciation2.330.440.440.440.430.460.400.430.380.390.390.390.39
Profit before tax-11.18-4.29-4.47-1.64-3.85-9.61-2.41-3.96-2.13-1.299.597.985.50
Tax %-15.21%0.00%0.00%0.00%0.78%0.00%0.00%0.00%0.00%13.95%0.00%0.00%0.00%
Net Profit +-9.48-4.29-4.47-1.64-3.88-9.61-2.41-3.96-2.13-1.469.587.985.50
EPS in Rs-1.92-1.64-1.71-0.62-1.48-3.66-0.92-1.51-0.81-0.503.252.711.87

Financials of Brooks Laboratories

Profit & Loss

Annual income statement trend

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +779163798389
Expenses +7710593979184
Operating Profit1-14-30-18-85
OPM %1%-16%-47%-22%-10%6%
Other Income +1111119
Interest332111
Depreciation777222
Profit before tax-9-24-38-20-1022
Tax %115%-19%-19%0%2%
Net Profit +-19-19-31-20-1022
EPS in Rs-7.40-4.31-7.97-7.46-3.387.33
Dividend Payout %0%0%0%0%0%

Financials of Brooks Laboratories

Balance Sheet

Capital structure and asset base

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital252525262929
Reserves546349396986
Borrowings +31257688
Other Liabilities +528329191816
Total Liabilities16219611090124140
Fixed Assets +10811015141413
CWIP1150001
Investments0064437486
Other Assets +547131343640
Total Assets16219611090124140

Financials of Brooks Laboratories

Cash Flows

Operating, investing and financing cash movement

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +4-37-14-103
Cash from Investing Activity +-5-2500-45
Cash from Financing Activity +164111042
Net Cash Flow02-30-0
Free Cash Flow-1-62-15-102
CFO/OP1,519%261%48%56%-26%

Financials of Brooks Laboratories

Ratios

Working capital efficiency and return ratios

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days6571747588
Inventory Days178157806061
Days Payable2331591659790
Cash Conversion Cycle968-123859
Working Capital Days-8534-373443
ROCE %-16%-30%-25%-10%